| scholarly article | Q13442814 |
| P50 | author | David J. Bond | Q52146724 |
| Flávio Kapczinski | Q77015947 | ||
| Márcia Kauer-Sant'Anna | Q77031571 | ||
| P2093 | author name string | Raymond W Lam | |
| Jan-Marie Kozicky | |||
| Joana Bücker | |||
| Kesavan Muralidharan | |||
| Lakshmi N Yatham | |||
| Leonardo E Silveira | |||
| Ivan J Torres | |||
| P2860 | cites work | A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment | Q22242399 |
| A rating scale for depression | Q24564540 | ||
| Meta-analysis of the acute effects of nicotine and smoking on human performance. | Q24621715 | ||
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. | Q45484599 | ||
| BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. | Q46025431 | ||
| Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians | Q46714706 | ||
| Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease | Q46745854 | ||
| Selective alterations within executive functions in adolescents with excess weight | Q47576386 | ||
| Brain-derived neurotrophic factor serum levels before and after treatment for acute mania | Q47969468 | ||
| Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study | Q48561754 | ||
| Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. | Q50475369 | ||
| 12-month longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder. | Q50677243 | ||
| Altered executive function in obesity. Exploration of the role of affective states on cognitive abilities. | Q50754048 | ||
| Neurocognitive functioning in patients recently diagnosed with bipolar disorder. | Q50759514 | ||
| Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder. | Q50778265 | ||
| Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. | Q50790550 | ||
| The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients. | Q50892593 | ||
| The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder. | Q51008916 | ||
| Body mass index and neuropsychological function in healthy children and adolescents. | Q51739939 | ||
| Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. | Q53283282 | ||
| Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study | Q57506033 | ||
| Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: A positive correlation | Q58950504 | ||
| The Association of Elevated Body Mass Index with Reduced Brain Volumes in First-Episode Mania | Q59488864 | ||
| Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study | Q73076616 | ||
| The positive and negative syndrome scale (PANSS) for schizophrenia | Q28301751 | ||
| The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 | Q29547745 | ||
| Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies | Q29614505 | ||
| A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
| The impact of childhood trauma on cognitive functioning in patients recently recovered from a first manic episode: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). | Q30581991 | ||
| Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania project | Q33414015 | ||
| The association of weight gain with mood symptoms and functional outcomes following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). | Q33702652 | ||
| Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study | Q33941073 | ||
| An 18-year follow-up of overweight and risk of Alzheimer disease | Q34214251 | ||
| Global assessment of functioning. A modified scale | Q34302424 | ||
| Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators | Q34325168 | ||
| Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. | Q34661363 | ||
| Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. | Q34735182 | ||
| The MATRICS consensus cognitive battery in patients with bipolar I disorder. | Q35112186 | ||
| The burden of obesity among adults with bipolar disorder in the United States | Q35167517 | ||
| Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. | Q35631515 | ||
| Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorder. | Q36068732 | ||
| Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. | Q36964951 | ||
| Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. | Q37171035 | ||
| Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder | Q37218782 | ||
| Early childhood obesity is associated with compromised cerebellar development | Q37255516 | ||
| Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study | Q37271525 | ||
| Effects of lithium on cognitive performance: a meta-analysis | Q37582048 | ||
| The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). | Q37773404 | ||
| Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis | Q37873034 | ||
| Evidence of executive dysfunction in extremely obese adolescents: a pilot study | Q39945711 | ||
| Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives | Q40062404 | ||
| Comparison of cognitive functions between first- and multi-episode bipolar affective disorders | Q40327664 | ||
| Neuropsychological functions in Han Chinese patients in Taiwan with bipolar II disorder comorbid and not comorbid with alcohol abuse/alcohol dependence disorder | Q43496092 | ||
| Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 | ||
| Body mass index, other cardiovascular risk factors, and hospitalization for dementia | Q43821126 | ||
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. | Q44142664 | ||
| Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 | ||
| Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode | Q44285187 | ||
| Relation between body mass index and cognitive function in healthy middle-aged men and women. | Q44583961 | ||
| Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults. | Q44601737 | ||
| Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder | Q44814767 | ||
| Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study | Q44996893 | ||
| Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients. | Q45003562 | ||
| Long-term outcome of cognitive impairment in bipolar disorder. | Q45075674 | ||
| The impact of age, weight and gender on BDNF levels in human platelets and plasma | Q45178135 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| bipolar disorder | Q131755 | ||
| P304 | page(s) | 639-648 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Canadian Journal of Psychiatry | Q5030253 |
| P1476 | title | Neurocognitive functioning in overweight and obese patients with bipolar disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM) | |
| P478 | volume | 59 |
| Q89057805 | Differential Impact of Obesity on CD69 Expression in Individuals with Bipolar Disorder and Healthy Controls |
| Q92760868 | Failure of activation of striatum during the performance of executive function tasks in adult patients with bipolar disorder |
| Q47997952 | Greater body mass index is associated with reduced frontal cortical volumes among adolescents with bipolar disorder. |
| Q55082082 | Greater body mass index is associated with reduced frontal cortical volumes among adolescents with bipolar disorder. |
| Q90428150 | Impact of metabolic syndrome and clinical features on functioning in patients with bipolar disorder: a cross-sectional study |
| Q47249575 | Lower cognitive functioning as a predictor of weight gain in bipolar disorder: a 12-month study. |
| Q57454956 | Neurococognitive and neuroimaging correlates of obesity and components of metabolic syndrome in bipolar disorder: a systematic review |
Search more.